Efavirenz, emtricitabine, tenofovir disoproxil fumarate

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

HIV

Manufacturer:

Bristol-Myers Squibb and Gilead Sciences

Brand Name:

Atripla

Project Line:

Reimbursement Review

Project Number:

SR0111-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

HIV

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

April 17, 2008

Last Updated : October 30, 2007